8-K: Waters Corporation Exceeds Q2 Expectations Despite Sales Dip, Cautious Outlook Remains

Waters Corporation reported second-quarter results that surpassed expectations, driven by strong performance in China and M&A contributions, despite a 4% decline in overall sales.

Summary

• Waters Corporation announced its second-quarter 2024 financial results, with sales of $709 million, a 4% decrease compared to $741 million in the same quarter of 2023.
• The company's GAAP earnings per share (EPS) was $2.40, down from $2.55 in the prior year, while non-GAAP EPS was $2.63, compared to $2.80 in the second quarter of 2023.
• The results exceeded the company's guidance due to better-than-expected performance in China and higher-than-expected M&A contributions from the Wyatt acquisition.
• Sales into the pharmaceutical market decreased by 3%, the industrial market decreased by 4%, and the academic and government market decreased by 15%.
• Instrument system sales decreased by 14%, while recurring revenues increased by 4%.
• Geographically, sales in Asia decreased by 7%, the Americas decreased by 3%, and Europe decreased by 3%.
• The company has revised its full-year 2024 organic constant currency sales growth to a range of -2.0% to -0.5%.
• Full-year 2024 non-GAAP EPS is expected to be in the range of $11.55 to $11.65.
• Third-quarter 2024 constant currency sales growth is expected to be in the range of +1.0% to +3.0%, with non-GAAP EPS between $2.60 and $2.70.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the company exceeding expectations for the quarter, but tempered by the overall sales decline and lowered full-year guidance. The management's positive outlook for the second half of the year adds a slightly optimistic tone.

Positives

• The company exceeded both top-line and bottom-line reported guidance for the second quarter.
• Margins remained resilient due to disciplined operational management, offsetting headwinds from volume, currency, and inflation.
• The company is building positive momentum and expects to return to growth in the second half of the year.
• Recurring revenues showed growth, increasing by 4% as reported and 5% in organic constant currency.
• The Wyatt acquisition contributed positively to sales, exceeding initial expectations.

Negatives

• Overall sales decreased by 4% compared to the same quarter last year.
• GAAP EPS decreased from $2.55 to $2.40 year-over-year.
• Non-GAAP EPS decreased from $2.80 to $2.63 year-over-year.
• Instrument system sales experienced a significant decrease of 14% as reported and 17% in organic constant currency.
• Sales in the academic and government market declined by 15% as reported and 16% in organic constant currency.
• The company has lowered its full-year sales growth outlook.

Risks

• The company faces potential for a more gradual market improvement in the second half of the year than previously anticipated.
• Unfavorable foreign exchange rates are expected to negatively impact full-year sales growth by approximately 1.5% and non-GAAP EPS by approximately 3%.
• The company is exposed to risks related to global economic, sovereign, and political conditions, including the impact of tariffs and trade regulations.
• The ongoing conflicts between Russia and Ukraine and in the Middle East could lead to further geopolitical and regulatory instability.
• The Chinese government's tightening of restrictions on procurement by government-funded customers poses a risk.
• The company's ability to access capital, maintain liquidity, and service debt could be impacted by volatile market conditions.
• There are risks associated with the introduction of competing products and loss of market share.
• The company faces risks related to cybersecurity and technology, including potential breaches of security measures.

Future Outlook

The company expects to return to growth in the second half of the year, with full-year organic constant currency sales growth between -2.0% and -0.5% and non-GAAP EPS between $11.55 and $11.65. Third-quarter constant currency sales growth is expected to be between +1.0% and +3.0%, with non-GAAP EPS between $2.60 and $2.70.

Management Comments

• Our team executed well to deliver second quarter results that exceeded both our top-line and bottom-line reported guidance, said Dr. Udit Batra, President & CEO, Waters Corporation.
• Our margins remained resilient, thanks to our disciplined approach to operational management, which offset headwinds from volume, currency, and inflation.
• We continue to build positive momentum in our business and expect to return to growth in the second half of the year.
• Looking further ahead, our steady stream of innovative new products positions us well in our attractive end markets.

Industry Context

Waters Corporation operates in the analytical instruments and software industry, serving the life, materials, food, and environmental sciences. The company's performance is influenced by factors such as pharmaceutical and industrial spending, government funding for research, and global economic conditions. The results reflect a mixed environment with some sectors showing weakness while others are more resilient.

Comparison to Industry Standards

• Waters' performance is being compared to other analytical instrument companies such as Agilent Technologies and Thermo Fisher Scientific.
• While Waters experienced a sales decline, some competitors have shown more resilience in certain sectors, particularly in the pharmaceutical market.
• The company's recurring revenue growth of 4% is a positive sign, as this is a key metric for stability and long-term growth in the industry.
• The impact of the Wyatt acquisition is a unique factor for Waters, and its contribution to sales is being closely monitored against industry benchmarks for M&A performance.
• The company's revised full-year outlook reflects a cautious approach, which is consistent with the broader industry trend of navigating economic uncertainties.

Stakeholder Impact

• Shareholders may react positively to the better-than-expected quarterly results, but negatively to the lowered full-year guidance.
• Employees may be impacted by the company's cost-saving initiatives and organizational restructurings.
• Customers may be affected by changes in product offerings and pricing.
• Suppliers may be impacted by changes in the company's supply chain and procurement practices.
• Creditors may be concerned about the company's debt levels and ability to service debt in volatile market conditions.

Next Steps

• The company will continue to focus on operational management to maintain margins.
• Waters will work to build positive momentum and return to growth in the second half of the year.
• The company will continue to develop and launch innovative new products.
• The company will host a conference call to discuss the results and outlook.

Key Dates

Keywords

Waters Corporation, Financial Results, Second Quarter, Sales, EPS, Organic Growth, Constant Currency, M&A, Wyatt, Pharmaceutical, Industrial, Academic, Government, Recurring Revenue, Guidance